mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach

The Journal of Allergy and Clinical Immunology: In Practice - Tập 9 Số 4 - Trang 1423-1437 - 2021
Aleena Banerji1,2, Paige G. Wickner3,2, Rebecca R. Saff1,2, Cosby A. Stone4, Lacey B. Robinson1,2, Aidan A. Long1,2, Anna R. Wolfson1,2, Paul V. Williams5, David A. Khan6, Elizabeth Phillips4, Kimberly G. Blumenthal1,7,2
1Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass
2Harvard Medical School, Boston, Mass
3Division of Allergy and Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
4Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
5Allergy Division, University of Washington School of Medicine, Seattle, Wash
6Division of Allergy & Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
7Edward P. Lawrence Center for Quality and Safety, Massachusetts General Hospital, Boston, Mass

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adeline

2021, Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14 – 23, 2020, MMWR, 70, 46

Polack, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577

McNeil, 2016, Risk of anaphylaxis after vaccination in children and adults, J Allergy Clin Immunol, 137, 868, 10.1016/j.jaci.2015.07.048

Stone, 2019, Immune-mediated adverse reactions to vaccines, Br J Clin Pharmacol, 85, 2694, 10.1111/bcp.14112

Nakayama, 2000, Change in gelatin content of vaccines associated with reduction in reports of allergic reactions, J Allergy Clin Immunol, 106, 591, 10.1067/mai.2000.108433

Andersen, 2013, MMR vaccination of children with egg allergy is safe, Dan Med J, 60, A4573

Stone, 2019, Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized, J Allergy Clin Immunol Pract, 7, 1533, 10.1016/j.jaip.2018.12.003

Krantz, 2020, Anaphylaxis to PEGylated liposomal echocardiogram contrast in a patient with IgE-mediated macrogol allergy, J Allergy Clin Immunol Pract, 8, 1416, 10.1016/j.jaip.2019.12.041

Yang, 2015, Anti-PEG immunity: emergence, characteristics, and unaddressed questions, Wiley Interdiscip Rev Nanomed Nanobiotechnol, 7, 655, 10.1002/wnan.1339

Zhou, 2021, Anti-PEG IgE in anaphylaxis associated with polyethylene glycol, J Allergy Clin Immunol Pract, 9, 1718, 10.1016/j.jaip.2020.11.011

Wenande, 2016, Immediate-type hypersensitivity to polyethylene glycols: a review, Clin Exp Allergy, 46, 907, 10.1111/cea.12760

Sellaturay, 2021, Polyethylene glycol-induced systemic allergic reactions (anaphylaxis), J Allergy Clin Immunol Pract, 9, 670, 10.1016/j.jaip.2020.09.029

Pidaparti, 2012, Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly, Pediatr Blood Cancer, 59, 436, 10.1002/pbc.23380

Hasan, 2017, Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review, Pediatr Blood Cancer, 64, 81, 10.1002/pbc.26200

Lee, 2016, Anaphylaxis to polyethylene glycol (Colyte®) in a patient with diverticulitis, J Korean Med Sci, 31, 1662, 10.3346/jkms.2016.31.10.1662

Coors, 2005, Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions, Ann Allergy Asthma Immunol, 95, 593, 10.1016/S1081-1206(10)61024-1

Hawe, 2010, Fluorescent molecular rotors as dyes to characterize polysorbate-containing IgG formulations, Pharm Res, 27, 314, 10.1007/s11095-009-0020-2

Price, 2007, Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy, Allergy Asthma Proc, 28, 313, 10.2500/aap.2007.28.3003

Badiu, 2012, Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80, BMJ Case Rep, 2012, 10.1136/bcr.02.2012.5797

Steele, 2005, Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin, Nephrology (Carlton), 10, 317, 10.1111/j.1440-1797.2005.00389.x

Limaye, 2002, An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity, J Allergy Clin Immunol, 110, 530, 10.1067/mai.2002.126460

Bibera, 2020, Potential cross-reactivity of polysorbate 80 and cremophor: a case report, J Oncol Pharm Pract, 26, 1279, 10.1177/1078155219896848

Palacios Castaño, 2016, Anaphylaxis due to the excipient polysorbate 80, J Investig Allergol Clin Immunol, 26, 394, 10.18176/jiaci.0109

Cabanillas

Voysey, 2020, Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, Lancet, 397, 99, 10.1016/S0140-6736(20)32661-1

Tannenbaum, 1975, Acute anaphylaxis associated with serum complement depletion, J Allergy Clin Immunol, 56, 226, 10.1016/0091-6749(75)90094-9

Szebeni, 1999, Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes: role of complement and inhibition by soluble CR1 and anti-C5a antibody, Circulation, 99, 2302, 10.1161/01.CIR.99.17.2302

de Vrieze

Neun, 2018, Understanding the role of anti-PEG antibodies in the complement activation by doxil in vitro, Molecules, 23, 1700, 10.3390/molecules23071700

Broyles, 2020, Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs, J Allergy Clin Immunol Pract, 8, S16, 10.1016/j.jaip.2020.08.006

Kelso, 2012, Adverse reactions to vaccines practice parameter 2012 update, J Allergy Clin Immunol, 130, 25, 10.1016/j.jaci.2012.04.003

Shaker, 2020, Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis, J Allergy Clin Immunol, 145, 10.1016/j.jaci.2020.01.017

Manivannan, 2009, Visual representation of National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network criteria for anaphylaxis, Int J Emerg Med, 2, 3, 10.1007/s12245-009-0093-z